MARVIN S MD HAUSMAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARVIN S MD HAUSMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARVIN S MD HAUSMAN. MARVIN S MD HAUSMAN is a Director in ARBIOS SYSTEMS INC ($ABOS) and a CEO, President, Acting CFO in Entia Biosciences, Inc. ($GMKG) and a Chairman, CSTO in Entia Biosciences, Inc. ($GMKG) and a Chairman,Chief Sci/Tech Offc in Entia Biosciences, Inc. ($GMKG) and a PRESIDENT, CEO in Entia Biosciences, Inc. ($GMKG).
Address: 825 THIRD AVE 40TH FL NEW YORK 10022 NY
Companies in which MARVIN S MD HAUSMAN is an Insider
ARBIOS SYSTEMS INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MARVIN S MD HAUSMAN: Director
Holdings: 0 shares
Latest Transaction: Feb 13 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Entia Biosciences, Inc.
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of MARVIN S MD HAUSMAN: Chairman, CSTO, Chairman,Chief Sci/Tech Offc, CEO, President, Acting CFO, PRESIDENT, CEO
Holdings: 8,838,900 shares
Latest Transaction: Feb 16 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARVIN S MD HAUSMAN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 250,000 | 0 | 10,188,900 | 9.9 M to 10.2 M (+2.52 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 300,000 | 0 | 9,938,900 | 9.6 M to 9.9 M (+3.11 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 200,000 | 0 | 9,638,900 | 9.4 M to 9.6 M (+2.12 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 600,000 | 0 | 9,438,900 | 8.8 M to 9.4 M (+6.79 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.18 | 1,861,170 | 325,705 | 8,838,900 | 7 M to 8.8 M (+26.67 %) |
| Dec 06 2016 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman,Chief Sci/ ... | Option Exercise | P | 0.10 | 40,000 | 4,000 | 40,000 | |
| Apr 28 2015 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | CEO, President, Act ... | Grant | A | 0.20 | 600,000 | 120,000 | 4,757,200 | 4.2 M to 4.8 M (+14.43 %) |